With over 30 years of varied business experience, I have raised capital, grown and sold businesses, worked in both the private and public sectors in small and large companies, managed small and large groups of people, and seen, solved and overcome a plethora of problems. But the real question is, how can I help you…..?Recent Accomplishments: Advising Top Tier Venture Capital Firm on Alzheimer’s Disease Company. Providing the President with an assessment of the clinical data, the next stage in the clinical development and commercial considerations to support a Series B financing Radiopharmaceutical oncology company, 2019 to date. Providing CEO and board strategic advice and supporting its series A financing and potential spin-off of its diagnostics business. European Gene Therapy company, 2019 to date. Advising company on readying itself to enter the US market for financing and the clinical development of its lead siRNA product in the cancer space. Large Biopharma, Cambridge, MA 2018 to 2019. Advising on novel approach to launch a proprietary monoclonal antibody product into a major new neuroscience $3.6 billion market  Oncology EU biotech firm, 2019 to date. Advising clinical stage EU company developing a novel therapeutic oncology biologic, in partnering program, negotiating collaborations and supporting its financing efforts POC and digital diagnostic company, Boston, 2018 to date Providing strategic and e-commerce partnership advice in the $9 billion STI diagnostic market Health IT company, Boston, 2018 to date Advising health IT company on strategy, business development and customer acquisition in the $150 billion appointment optimization business for US health systems European Cell Therapy Company, Acting CEO, 2017 to 2019 Providing leadership on financing, strategy, product development, and business development for a cell therapy approach in oncology. Obtained 8 million Euro grant in Janssen/NUIG consortium.

• Faculty, Health Sector Management MBA Program: coordinate and teach two case-based experiential classes, and provide student counseling and support. Advised student consulting projects with 3 companies• HM717 Drugs, Devices and Diagnostics: Strategy and Execution: an in-depth look at strategy and execution in the health sector product space; utilizing case studies and C level speakers to enhance the student experience. • HM 703 The Health Sector: Opportunities and Issues. Explores the payer, provider and product interfaces of the U.S. and global healthcare market, the economics, government role and data; identifies challenges and opportunities with industry leaders.